ACE Report Cover
Single shot ISBPB vs patient-controlled interscalene infusion for analgesia in rotator cuff repair
Language
Download
Cite
+ Favorites
Language
Download
Cite
+ Favorites
AceReport Image
SHOULDER & ELBOW
Single shot ISBPB vs patient-controlled interscalene infusion for analgesia in rotator cuff repair .

Interscalene brachial plexus bolus block versus patient-controlled interscalene indwelling catheter analgesia for the first 48 hours after arthroscopic rotator cuff repair

J Shoulder Elbow Surg. 2018 Jul;27(7):1243-1250
Contributing Authors

YS Kim JH Kim HJ Lee HJ Koh DK Kim KY Lee KH Kwon

154 patients scheduled for arthroscopic rotator cuff repair were randomized to either a single-shot interscalene brachial plexus block (ssISBPB). patient-controlled interscalene infusion analgesia (PCIA) postoperatively, or to a control group not administered additional analgesia. The purpose was to compare pain scores from 1 hour to 48 hours after surgery. There were marked differences in pain score trajectory between the two intervention groups, with significantly lower pain at 1 and 2 hours in the ssISBPB group compared to the PCIA group, but significantly lower pain in the PCIA group compared to the ssISBPB group at 12 and 24 hours postoperatively.

Unlock the Full ACE Report

You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now

Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics

Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics

Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions

Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics

Or upgrade today and gain access to all OrthoEvidence
content for as little as $1.99 per week.
0 of 4 monthly FREE articles unlocked
You've reached your limit of 4 free articles views this month

Access to OrthoEvidence for as little as $1.99 per week.

Stay connected with latest evidence. Cancel at any time.
  • Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
  • Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
  • Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Upgrade
Welcome Back!
Forgot Password?
Start your FREE trial today!

Account will be affiliated with


OR
Forgot Password?

OR
Please check your email

If an account exists with the provided email address, a password reset email will be sent to you. If you don't see an email, please check your spam or junk folder.

For further assistance, contact our support team.

Translate ACE Report

OrthoEvidence utilizes a third-party translation service to make content accessible in multiple languages. Please note that while every effort is made to ensure accuracy, translations may not always be perfect.

Cite this ACE Report

OrthoEvidence. Single shot ISBPB vs patient-controlled interscalene infusion for analgesia in rotator cuff repair. ACE Report. 2019;8(2):78. Available from: https://myorthoevidence.com/AceReport/Show/single-shot-isbpb-vs-patient-controlled-interscalene-infusion-for-analgesia-in-rotator-cuff-repair

Copy Citation
Please login to enable this feature

To access this feature, you must be logged into an active OrthoEvidence account. Please log in or create a FREE trial account.

Premium Member Feature

To access this feature, you must be logged into a premium OrthoEvidence account.

Share this ACE Report